Oxford Medical Simulation (OMS) provides VR-based simulation training to healthcare professionals with AI-controlled patients. The simulations focus on crisis resource management, team interaction, patient engagement, and decision making under pressure, where the users can practice in various clinical scenarios. The company claims that the use of its platform allows for a 74% reduction in staffing and estate costs.
Other platform features include multi-participant and multi-patient sessions, voice control for enhanced realism, and hand interactions to build muscle memory. Further, the platform also provides performance-based feedback to understand areas of improvement and ten in-built frameworks to analyze competency.
The company also offers a no-code platform (OMS Create) for the creation of medical VR simulations, with options to adjust the difficulty of skills tested or other modifications to its 240+ existing simulations.
Key customers and partnerships
As of January 2024, the company worked with over 150 healthcare training institutions worldwide, with notable clients including several NHS Trusts and universities such as John Hopkins University and Duke University.
Funding and financials
The company’s most recent funding round was in January 2024, where it raised USD 12.6 million in Series A funding led by Frog Capital. The company aims to designate the fresh capital toward scaling its operations, expanding its offering across multiple learning groups, and integrating AI into its solutions. It also plans to aid and support its clients in curating their content.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.